[Efficacy and safety of piperacillin-tazobactam for febrile neutropenic patients in Japan].

Miyazaki, Koji; Kamata, Hirotoshi; Kimura, Hirokazu; Okina, Sosei; Ishii, Ryuji; Osaka, Manabu; Danbara, Mikio; Horie, Ryouichi; Higashihara, Masaaki

Miyazaki, Koji; Kamata, Hirotoshi; Kimura, Hirokazu; Okina, Sosei; Ishii, Ryuji; Osaka, Manabu; Danbara, Mikio; Horie, Ryouichi; Higashihara, Masaaki.

Affiliation

Miyazaki K; Department of Hematology, Kitasato University School of Medicine.

Rinsho Ketsueki ; 53(7): 686-90, 2012 Jul.

Article in Ja | MEDLINE | ID: mdl-22975770

Subject(s)

Anti-Bacterial Agents/administration & dosage; Neutropenia/drug therapy; Female; Fever/drug therapy; Fever/etiology; Hematologic Neoplasms/complications; Humans; Japan; Male; Middle Aged; Neutropenia/etiology; Penicillanic Acid/administration & dosage; Penicillanic Acid/adverse effects; Penicillanic Acid/analogs & derivatives; Piperacillin/administration & dosage; Piperacillin/adverse effects; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Anti-Bacterial Agents / Neutropenia Type of study: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: Ja Journal: Rinsho Ketsueki Year: 2012 Document type: Article Country of publication: Japan

Search on Google

Add to My VHL

XML

PubMed Links